Tag | Content |
---|
EnhancerAtlas ID | HS017-00189 |
Organism | Homo sapiens |
Tissue/cell | CD14+_monocyte |
Coordinate | chr1:9728820-9730840 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
MIXL1 | MA0662.1 | chr1:9729227-9729237 | TCTAATTAAC | + | 6.02 |
|
| Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
SE_09834 | chr1:9729126-9731010 | CD14 | SE_11127 | chr1:9727719-9732748 | CD20 | SE_18450 | chr1:9727690-9734609 | CD4p_CD25-_Il17-_PMAstim_Th | SE_19640 | chr1:9728783-9732689 | CD4p_CD25-_Il17p_PMAstim_Th17 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| Number: 1 | ID | Chromosome | Start | End |
GH01I009669 | chr1 | 9729127 | 9731010 |
|
Enhancer Sequence | CAACCTCTTT CTGTCCAAAT AGACTGTGTC CTCGGCTGGC TGACTGGATC TGGGTGTGAG 60 CCTCCCTGAG CAAGCCGGTG AACCTCTCCC ATGTGGTCTT AGCTCCCTGA GCAGATGAGT 120 AGGGGCTGAC GGGGCTGTGT CTCCAGGACT CTGAGTCTGC TGTGGTCCTG CAGCCTCTGG 180 AGCATGGAAA TGGGGGCTAA GGACTCACTA ATGGTTTCAT TCAAGTCCAG AATTTGTCTT 240 GGTGACTGTT CGCTGCTCAC ATCCAGATGA CCCTATATGC TGTTTGGGAA ACTGAGGCAG 300 CCAGGTGGAT TCCTCAGGTA TTTCAGGGGA CAGAATCTGG GGCTTTGACT CCAGCTTGGG 360 TTGCTGCCCA TAATGCCTGC TCTTGAAACC TTTTAATTAT TTTTATTTCT AATTAACTTT 420 TTTTGAGACA AGGTCTTGCT CTGTCACCCA GGGTGCAGTG CAGTGGAGCT ATCATAGCTC 480 ATTGCAGCCT CAGTCTCCTG GGTTCAAGTG ATCCGCCCAC CTAGTAGTTG GGACAACAGG 540 CATATGCCAC CACACCCGGG TAATTTTTGT AGCTTTTTGT AGAGATGGAG GTCTCCTTTT 600 GTTGCCCAGG CTTATTCTGA GTCAACATGA GTGACCATGG CCCAAGAAAC AGTCTCAAGA 660 GGTCCTGAGA AAGTGTGCCC AAGACGATTG GGTTACAGTT TGGTTTTATG CATTTTAGGA 720 AGACAGGAAT TGTAGGTAAA ATCATAAATC AGTACATGAA AAGTATACAT TGGTTCAGGT 780 CTCAAACTCC TGGGCTCAAG CGATCTTCCT GCCTCGGCCT CGCAAAGTAC TGGGATTACG 840 GGCATGAGCC TGCGCCAGAC CTCTTAAACC CTTCAGAGTG GCCTTGGCAT TCGTTTTGAG 900 GGGGCTTCAG GGAGCCTTAA GGGAGGAGAG GAAAGTCACG CAAACAGGGT GTGCTTGATG 960 CCTGCATTTT CCTCTTTACT GCTGACCTGC TGTTGAGGAG GAAGTTAAGA ACATCAGGAT 1020 ATTGGTCTCA AATGAACTAC TTCATGAGAA TTTTCTTCTA GGAGGAAAAA CAAAAACCTC 1080 AACTTTCTCG TTACACATCC TTCTAAAAAA GTCCATTAAA AATGTTTCTT GCCAGGCGCG 1140 GTGGCTCACG CCTGTAATCC CAACACTTTG GGAGGCCAAA GCAGGTGGAT TACCTGAGAT 1200 CAGGAGTTCG AGACCAGCCT GGCCAACATG GTGAAACCCT GTCTCTACTA AAAATACAAA 1260 AATTAGCTGG GCGTGGTGGT GGGTGCCTAT AATCCCAGCT AATTAGGAGG CTGAGACAGG 1320 AGAATCACTT GAACCTGGGA GGCAGAGGTT GCACTCCAGC CTGGGTGACA AGAGAGAAAT 1380 TCCACCTCAA AAAAAAAAAA AAAAAAAAAA GTTCCTCATA TTCAGAGCCA AGGAAAGGAG 1440 ATGTACTCCC AGACCACAAC TTCTGTTTCT GATGGTTTCA AGCATCCAGG AGCCATGACC 1500 AGGTCATGAA TCTTTTTTTC CCTATTGTGT GGTGTGATGA GTATTTGAAT AATACAGCCC 1560 ATCTGCTGTC ATTTGGAAAC CGGTGATGAT GTGTGGTCTA TTTGTAAATT GAGTGCAGCA 1620 CATCTAATAT GTGATAGTTT CCTAAGATGT GAATGGCTCC ATTTCTCCAG CAGGACCGTG 1680 TTTTGAAAAT GAATAAAAGG TTAGCTTCAG ATTAGCATTA AAAGCAAGAG TTTTAGAATT 1740 ACAGGCTTCA TATCTTGGCT TTGACACTTA ACATGTAGGG GACCTTGACA AGTTATTTAA 1800 GTTTCTGGGT TCTCATCTGA GAATTAGGAT GATAGTACCT CTTTGACTGG ATTGTCGTAG 1860 AGATGTCGTA AAGATTGGAA ATAATGAAAC ACCTGGACCA AGTTATGGGT ACCCAAAAAG 1920 TTGCAGTTTT TACCATTGGA TGAATGAATC TTTGAGGCCC ACACTGTGGT AGGGAGTGGA 1980 TTTTTAAAAA ACAATTTGTT TTTGGTTTTT TTTTAGATGG 2020
|